My Anoro Ellipta medicine
This page is specifically for patients who have been prescribed Anoro Ellipta. If you are not a patient please return to the public website.
What is Anoro Ellipta?
Anoro Ellipta contains two active substances called umeclidinium and vilanterol. These belong to a group of medicines called bronchodilators.1
How does Anoro Ellipta work?
Anoro Ellipta is used to treat chronic obstructive pulmonary disease (COPD) in adults. COPD is a long term condition characterised by breathing difficulties that slowly get worse.1
In COPD the muscles around the airways tighten. This medicine blocks the tightening of these muscles in the lungs, making it easier for air to get in and out of the lungs. When used regularly, it can help to control your breathing difficulties and reduce the effects of COPD on your everyday life.1
Anoro Ellipta should not be used to relieve a sudden attack of breathlessness or wheezing. If you get this sort of attack you must use a quick-acting reliever inhaler (such as salbutamol).1
How do I take Anoro Ellipta?
Always use this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.1
The recommended dose is one inhalation every day at the same time of day. You only need to inhale once a day because the effect of this medicine lasts for 24 hours.1
Don’t use more than your doctor tells you to use.1
Use Anoro Ellipta regularly. It is very important that you use Anoro Ellipta every day, as instructed by your doctor. This will help to keep you free of symptoms throughout the day and night.1
Anoro Ellipta should not be used to relieve a sudden attack of breathlessness or wheezing. If you get this sort of attack you must use a quick-acting reliever inhaler (such as salbutamol).1
Do I still need to use my reliever inhaler?
Yes. Anoro Ellipta should not be used to relieve a sudden attack of breathlessness or wheezing. If you get this sort of attack you must use a quick-acting reliever inhaler (such as salbutamol).1
References:
- Anoro Ellipta 55/22mcg patient information leaflet, Last accessed: February 2023
ANORO Ellipta was developed in collaboration with INNOVIVA Inc.
▼This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting side effects you may get.
If you get any side effects, talk to your doctor or pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via HPRA Pharmacovigilance, Website: www.hpra.ie. By reporting side effects you can help provide more information on the safety of this medicine.
Anoro and Ellipta are registered trademarks of the GlaxoSmithKline group of companies.
